Pharming Group N.V.
OTC: PHGUF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Fabrice Chouraqui
- Employees
- 404
- Headquarters
- Leiden, Netherlands
- IPO year
- 2002
- Market cap
- $812.2M
- Website
- https://www.pharming.com
Loading PHGUF…
Loading profile data…Frequently asked questions about PHGUF
What does Pharming Group N.V. (PHGUF) do?
Pharming Group N.V. operates as a biopharmaceutical firm focused on creating and commercializing protein replacement therapies and precision medicines. These specialized treatments target rare diseases and areas with critical unmet medical needs, reaching patients throughout the United States, Europe, and other international regions. Pharming's...
Where does PHGUF trade?
Pharming Group N.V. (PHGUF) trades on the Other OTC.
What sector is PHGUF in?
Pharming Group N.V. (PHGUF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pharming Group N.V.?
Fabrice Chouraqui is the chief executive officer of Pharming Group N.V. (PHGUF).
Where is Pharming Group N.V. headquartered?
Pharming Group N.V. is headquartered in Netherlands.
Does PHGUF pay a dividend?
Pharming Group N.V. (PHGUF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PHGUF go public?
Pharming Group N.V. (PHGUF) completed its initial public offering in 2002.